1. Home
  2. R vs IMVT Comparison

R vs IMVT Comparison

Compare R & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$247.99

Market Cap

10.6B

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$44.10

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
IMVT
Founded
1933
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
8.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
R
IMVT
Price
$247.99
$44.10
Analyst Decision
Buy
Buy
Analyst Count
10
8
Target Price
$238.56
$33.00
AVG Volume (30 Days)
303.7K
1.0M
Earning Date
04-23-2026
05-28-2026
Dividend Yield
1.48%
N/A
EPS Growth
7.96
N/A
EPS
5.71
N/A
Revenue
$12,665,000,000.00
N/A
Revenue This Year
$5.00
N/A
Revenue Next Year
$5.05
N/A
P/E Ratio
$43.88
N/A
Revenue Growth
0.23
N/A
52 Week Low
$157.77
$14.47
52 Week High
$284.25
$45.42

Technical Indicators

Market Signals
Indicator
R
IMVT
Relative Strength Index (RSI) 34.13 69.87
Support Level $206.69 $37.16
Resistance Level $259.00 N/A
Average True Range (ATR) 5.71 1.55
MACD -1.44 0.40
Stochastic Oscillator 4.84 88.89

Price Performance

Historical Comparison
R
IMVT

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: